Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

WS06.03 A real-world evaluation of remote monitoring in cystic fibrosis care: a mixed-methods multicentre observational study

Autor: Oppelaar, M., Bannier, M., Reijers, M., Conemans, L., van der Vaart, H., Rottier, B., van der Meer, R., Nuijsink, M., Altenburg, J., van den Wijngaart, L., Merkus, P., Roukema, J.

Publikováno v: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S12-S13

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results

Autor: Bradley, Jm, Koker, P, Deng, Q, Moroni Zentgraf, P, Ratjen, F, Geller, De, Elborn, Js, Clements, B, Greville, H, Middleton, P, Serisier, D, van Asperen, P, Dupont, L, Knoop, C, Malfroot, A, Belleguic, C, Chiron, R, Derelle, J, Dominique, S, Dusser, D, Ginies, Jl, Guillot, M, Horeau-Langlard, D, Le Bourgeois, M, Leroy, S, Marguet, C, Munck, A, Pautard, Jc, Reix, P, Uffredi, Ml, Ballmann, M, Bargon, J, Fischer, R, Herth, F, Heuer, He, Griese, M, Kamin, W, Kohlhäufl, M, Nährlich, L, Riethmüller, J, Sorichter, S, Wagner, T, Bennett, L, Crawford, M, Crossley, J, Derry, D, Doull, I, Elborn, J, Everard, M, Groggins, C, Johnson, M, Lee, T, Rayner, R, Reid, A, Smyth, A, Southern, K, Thomas, D, Walshaw, M, Whitehouse, J, Braggion, C, De Rose, V, Gagliardini, R, Minicucci, L, Reijers, M, Tiddens, Ha, O'Carroll, M, Wong, J, Barreto, C, Cardim, P, Loureiro, M, Rocha, H, Vaz, Ml, Asherova, I, Chepurnaya, M, Chuchalin, Ag, Ilkovich, M, Kapranov, N, Neretina, A, Orlov, A, Simonova, O, Ahrens, R, Anbar, R, Biller, J, Carveth, H, Daines, C, Fiel, S, Flume, P, Froh, D, 3rd, Harris J., Howenstine, M, Millard, Dl, Nasr, S, Parker, H, Pian, M, Royall, J, Sabogal, C, Salathe, M, Sannuti, A, Schaeffer, D, Strausbaugh, S, Toder, D, Reyes, S, Whittaker, L, Zanni, R.

Publikováno v: PLoS ONE
Bradley, J M, Koker, P, Deng, Q, Moroni-Zentgraf, P, Ratjen, F, Geller, D E & Elborn, S 2014, ' Testing two different doses of tiotropium Respimat® in cystic fibrosis: Phase 2 randomized trial results ', PLoS ONE, vol. 9, no. 9, e106195, pp. 1-9 . https://doi.org/10.1371/journal.pone.0106195
PLoS ONE, Vol 9, Iss 9, p e106195 (2014)

Background Tiotropium is a once-daily, long-acting anticholinergic bronchodilator with the potential to alleviate airway obstruction in cystic fibrosis. Our objective was to evaluate the efficacy and safety of 2.5 and 5 µg once-daily tiotropium deli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6a0f6fd01cdda96e98323be257e434
http://europepmc.org/articles/PMC4154718

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Amsterdam duur van antiretrovirale therapie (ADAM)--onderzoek: inductie-onderhoudsbehandeling bij HIV-I-infectie, preliminaire resultaten

Autor: Reijers, M. H., Weverling, G. J., Jurriaans, S., Wit, F. W., van Leeuwen, R., Bruisten, S. M., Frissen, P. H., Weigel, H. M., Mulder, J. W., ten Kate, R. W., de Wolf, F., Schuitemaker, H., Lange, J. M.

Publikováno v: Nederlands tijdschrift voor geneeskunde, 142(40). Bohn Stafleu van Loghum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::9e8cde94638cfabdfab2bbe49c63c2dc
https://pure.amc.nl/en/publications/amsterdam-duur-van-antiretrovirale-therapie-adamonderzoek-inductieonderhoudsbehandeling-bij-hiviinfectie-preliminaire-resultaten(c20b5888-f4bd-475a-b7f9-e4167bfce4e1).html